| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
4,419 |
2,573 |
$2.60M |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
432 |
224 |
$364K |
| 65800 |
|
4,013 |
2,620 |
$175K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
1,884 |
1,671 |
$65K |
| 92134 |
|
4,169 |
3,591 |
$61K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
1,241 |
1,197 |
$50K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
601 |
465 |
$17K |
| 92201 |
|
481 |
469 |
$6K |
| 92242 |
|
52 |
52 |
$4K |
| 92226 |
|
236 |
118 |
$3K |
| J9035 |
Injection, bevacizumab, 10 mg |
46 |
45 |
$1K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
12 |
12 |
$899.75 |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
17 |
17 |
$231.45 |
| 92202 |
|
41 |
40 |
$116.10 |
| 92020 |
|
14 |
14 |
$10.48 |
| 1036F |
|
779 |
763 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
781 |
765 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
788 |
771 |
$0.00 |
| G9974 |
Dilated macular exam performed, including documentation of the presence or absence of macular thickening or geographic atrophy or hemorrhage and the level of macular degeneration severity |
12 |
12 |
$0.00 |